Skip to main content

MoneyWorks4Me

Aurobindo Pharma informs about analyst meet

28 May 2018 Evaluate

Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has informed that an analyst / investor call on the Audited Financial Results of the Company for the Year ended 31st March, 2018 is scheduled on 29th May, 2018 at 8:30 AM.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1760.40
Dr. Reddys Labs. 1341.90
Cipla 1364.90
Lupin 1985.00
Zydus Lifesciences 1183.85
View more..